Krystal Biotech, Inc. — Revenue by Fiscal Year
5 fiscal years, as filed with the SEC; every row links its evidence fact.
Cite as: FACTANKER, https://factanker.com/entity/2b6b908a-d161-4dd2-8244-a7ab4ff81dc1/serie/revenue
| Fiscal year | Revenue | Period | Evidence |
|---|---|---|---|
| FY 2025 | $389.1M | 2025-01-01 – 2025-12-31 | evidence 0001711279-26-000016 |
| FY 2024 | $290.5M | 2024-01-01 – 2024-12-31 | evidence 0001711279-25-000008 |
| FY 2023 | $50.7M | 2023-01-01 – 2023-12-31 | evidence 0001711279-24-000005 |
| FY 2022 | $0 | 2022-01-01 – 2022-12-31 | evidence 0001711279-24-000005 |
| FY 2021 | $0 | 2021-01-01 – 2021-12-31 | evidence 0001711279-24-000005 |
Methodology & sources
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
Krystal Biotech, Inc. — all facts · Net Income · Operating Income